Recommendation of the President – Gyroscopic stereotactic teleradiotherapy (TSZ) using a novel ZAP-X device

On 24 July 2024,  the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 80/2024 on the legitimacy of the qualification of the health care service “Gyroscopic stereotactic teleradiotherapy (TSZ) with the use of the innovative ZAP-X device” as a guaranteed benefit of hospital treatment

Publication in Public Information Bulletin (BIP) >>